Lene Uhrbom

4.3k total citations
56 papers, 2.4k citations indexed

About

Lene Uhrbom is a scholar working on Molecular Biology, Genetics and Cancer Research. According to data from OpenAlex, Lene Uhrbom has authored 56 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 24 papers in Genetics and 20 papers in Cancer Research. Recurrent topics in Lene Uhrbom's work include Glioma Diagnosis and Treatment (24 papers), MicroRNA in disease regulation (12 papers) and Cancer Cells and Metastasis (10 papers). Lene Uhrbom is often cited by papers focused on Glioma Diagnosis and Treatment (24 papers), MicroRNA in disease regulation (12 papers) and Cancer Cells and Metastasis (10 papers). Lene Uhrbom collaborates with scholars based in Sweden, United States and United Kingdom. Lene Uhrbom's co-authors include Bengt Westermark, Eric C. Holland, Monica Nistér, Göran Hesselager, Yiwen Jiang, Marianne Kastemar, Tommie Olofsson, Nanna Lindberg, Chengkai Dai and Gregory N. Fuller and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Nature Medicine.

In The Last Decade

Lene Uhrbom

52 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lene Uhrbom Sweden 29 1.3k 966 691 678 402 56 2.4k
Joseph Celestino United States 20 1.5k 1.1× 844 0.9× 741 1.1× 931 1.4× 256 0.6× 46 2.7k
Dwain K. Irvin United States 17 1.3k 1.0× 822 0.9× 550 0.8× 1.2k 1.8× 411 1.0× 21 2.5k
Ugo Orfanelli Italy 12 1.5k 1.1× 982 1.0× 702 1.0× 1.1k 1.6× 338 0.8× 17 2.8k
Benito Campos Germany 24 1.5k 1.1× 1.0k 1.1× 873 1.3× 1.0k 1.5× 299 0.7× 44 2.8k
Giuseppe Lamorte Italy 22 1.5k 1.1× 526 0.5× 441 0.6× 804 1.2× 245 0.6× 44 2.5k
Jarek Maciaczyk Germany 26 1.5k 1.1× 731 0.8× 755 1.1× 691 1.0× 182 0.5× 63 2.5k
Federica Pisati Italy 28 1.5k 1.1× 674 0.7× 369 0.5× 516 0.8× 222 0.6× 55 2.4k
Nikki Charles United States 8 940 0.7× 998 1.0× 647 0.9× 709 1.0× 581 1.4× 9 2.2k
David P. Noske Netherlands 29 1.5k 1.1× 641 0.7× 728 1.1× 706 1.0× 234 0.6× 69 2.7k
Per Øystein Sakariassen Norway 19 1.1k 0.8× 863 0.9× 872 1.3× 1.1k 1.6× 224 0.6× 25 2.4k

Countries citing papers authored by Lene Uhrbom

Since Specialization
Citations

This map shows the geographic impact of Lene Uhrbom's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lene Uhrbom with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lene Uhrbom more than expected).

Fields of papers citing papers by Lene Uhrbom

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lene Uhrbom. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lene Uhrbom. The network helps show where Lene Uhrbom may publish in the future.

Co-authorship network of co-authors of Lene Uhrbom

This figure shows the co-authorship network connecting the top 25 collaborators of Lene Uhrbom. A scholar is included among the top collaborators of Lene Uhrbom based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lene Uhrbom. Lene Uhrbom is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Damhofer, Helene, Tülin Tatar, Benjamin Southgate, et al.. (2024). TAK1 inhibition leads to RIPK1-dependent apoptosis in immune-activated cancers. Cell Death and Disease. 15(4). 273–273. 6 indexed citations
2.
Ilkhanizadeh, Shirin, Andreas Åslund, Marcus Bäck, et al.. (2023). Live Detection of Neural Progenitors and Glioblastoma Cells by an Oligothiophene Derivative. ACS Applied Bio Materials. 6(9). 3790–3797. 1 indexed citations
3.
Babačić, Haris, Silvia Galardi, Husen M. Umer, et al.. (2022). Glioblastoma stem cells express non‐canonical proteins and exclusive mesenchymal‐like or non‐mesenchymal‐like protein signatures. Molecular Oncology. 17(2). 238–260. 3 indexed citations
4.
Lu, Xi, Malin Jarvius, Yonglong Dang, et al.. (2022). Cell-lineage controlled epigenetic regulation in glioblastoma stem cells determines functionally distinct subgroups and predicts patient survival. Nature Communications. 13(1). 2236–2236. 15 indexed citations
5.
Xie, Yuan, Liqun He, Roberta Lugano, et al.. (2021). Key molecular alterations in endothelial cells in human glioblastoma uncovered through single-cell RNA sequencing. JCI Insight. 6(15). 100 indexed citations
6.
Bengtsson, Johan, Sara Bolin, Bengt Westermark, et al.. (2019). BET and Aurora Kinase A inhibitors synergize against MYCN-positive human glioblastoma cells. Cell Death and Disease. 10(12). 881–881. 25 indexed citations
7.
Tan, E‐Jean, Yuan Xie, Anders Sundström, et al.. (2019). A molecularly distinct subset of glioblastoma requires serum‐containing media to establish sustainable bona fide glioblastoma stem cell cultures. Glia. 68(6). 1228–1240. 5 indexed citations
8.
Zhang, Xing‐Mei, Sara Bolin, Anne‐Laure Joly, et al.. (2018). Microglia Induce PDGFRB Expression in Glioma Cells to Enhance Their Migratory Capacity. iScience. 9. 71–83. 38 indexed citations
9.
Xie, Yuan, Anders Sundström, E‐Jean Tan, et al.. (2018). LGR5 promotes tumorigenicity and invasion of glioblastoma stem‐like cells and is a potential therapeutic target for a subset of glioblastoma patients. The Journal of Pathology. 247(2). 228–240. 21 indexed citations
10.
Jiang, Yiwen, Voichita D. Marinescu, Yuan Xie, et al.. (2017). Glioblastoma Cell Malignancy and Drug Sensitivity Are Affected by the Cell of Origin. Cell Reports. 18(4). 977–990. 52 indexed citations
11.
Sreedharan, Smitha, Yuan Xie, Anders Sundström, et al.. (2016). Mouse Models of Pediatric Supratentorial High-grade Glioma Reveal How Cell-of-Origin Influences Tumor Development and Phenotype. Cancer Research. 77(3). 802–812. 16 indexed citations
12.
Pietras, Alexander, Tatsuya Ozawa, Elena Bazzoli, et al.. (2016). ABCG2 regulates self-renewal and stem cell marker expression but not tumorigenicity or radiation resistance of glioma cells. Scientific Reports. 6(1). 25956–25956. 44 indexed citations
13.
Jin, Zhe, Amol K. Bhandage, Sergiy V. Korol, et al.. (2014). Etomidate, propofol and diazepam potentiate GABA-evoked GABAA currents in a cell line derived from human glioblastoma. European Journal of Pharmacology. 748. 101–107. 18 indexed citations
14.
Krajisnik, Tijana, et al.. (2012). Abstract 3343: Upregulation of SOX5 perturbs human glioma cell proliferation and is associated with proneural glioblastoma. Cancer Research. 72(8_Supplement). 3343–3343. 1 indexed citations
15.
Kastemar, Marianne, Ida Waern, Irina Alafuzoff, et al.. (2011). Mast Cell Accumulation in Glioblastoma with a Potential Role for Stem Cell Factor and Chemokine CXCL12. PLoS ONE. 6(9). e25222–e25222. 62 indexed citations
16.
17.
Ferletta, Maria, et al.. (2010). Forced expression of Sox21 inhibits Sox2 and induces apoptosis in human glioma cells. International Journal of Cancer. 129(1). 45–60. 41 indexed citations
18.
Tchougounova, Elena, Yiwen Jiang, Nanna Lindberg, et al.. (2009). Sox5 can suppress platelet-derived growth factor B-induced glioma development in Ink4a-deficient mice through induction of acute cellular senescence. Oncogene. 28(12). 1537–1548. 29 indexed citations
19.
Lindberg, Nanna, Marianne Kastemar, Tommie Olofsson, Anja Smits, & Lene Uhrbom. (2009). Oligodendrocyte progenitor cells can act as cell of origin for experimental glioma. Oncogene. 28(23). 2266–2275. 148 indexed citations
20.
Uhrbom, Lene & Eric C. Holland. (2001). Modeling Gliomagenesis with Somatic Cell Gene Transfer using Retroviral Vectors. Journal of Neuro-Oncology. 53(3). 297–305. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joseph Celestino Breakdown of academic impact, for papers by Dwain K. Irvin Breakdown of academic impact, for papers by Ugo Orfanelli Breakdown of academic impact, for papers by Benito Campos Breakdown of academic impact, for papers by Giuseppe Lamorte Breakdown of academic impact, for papers by Jarek Maciaczyk Breakdown of academic impact, for papers by Federica Pisati Breakdown of academic impact, for papers by Nikki Charles Breakdown of academic impact, for papers by David P. Noske Breakdown of academic impact, for papers by Per Øystein Sakariassen
Rankless by CCL
2026